Gastric cancer is one of the most common gastrointestinal malignancies associated with
higher mortality and a high recurrence rate. Early detected gastric cancer can be managed …

Gastric cancer is one of the most common malignant tumors in the world. Its incidence ranks
fifth among all malignant tumors worldwide and is the third leading cause of death among …

According to the results of two recent randomized studies of treatment for metastatic gastric
cancer in Japan, S-1 could replace infusional 5-fluorouracil and S-1 plus cisplatin showed a …

Although recent phase II studies have demonstrated high antitumor activity in the treatment
of advanced gastric cancer, no significant survival benefit has been clearly demonstrated …

Despite a decreased incidence, gastric cancer remains a leading cause of death worldwide.
The only potentially curative modality for localised gastric cancer is surgery. However …

Simple Summary Outcomes for patients with advanced gastric cancer continue to be
unsatisfactory despite the inclusion of new targeted therapies in the treatment options. The …

The incidence of gastric cancer ranks 4th in malignant tumors, and the mortality rate ranks
3rd in malignant tumors. Most patients with gastric cancer are already at the advanced stage …

Background Gastric cancer is the fourth most common cancer worldwide. Surgery in
combination with multimodal therapy provides the only curative therapy until now. The …

In spite of a worldwide decrease in the incidence of gastric cancer, this malignancy still
remains one of the leading causes of cancer mortality. Great efforts have been made to …

Gastric cancer is the second leading cause of cancer related-death. Most patients present
with an advanced stage of disease that has a dismal outcome. Evidently, there is a clear …